Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Xanomeline–trospium beneficial in treatment of schizophrenia

Xanomeline–trospium beneficial in treatment of schizophrenia

16 Jan 2024
Repotrectinib shows high response rates, durable activity in ROS1 fusion–positive NSCLC

Repotrectinib shows high response rates, durable activity in ROS1 fusion–positive NSCLC

15 Jan 2024